Skip to main content
. 2022 Jan 13;14(1):e21219. doi: 10.7759/cureus.21219

Figure 2. Percentage of patients reporting PHQ-9 scores with a minimal clinically important difference (MCID) (5+ reduction) and remission at endline.

Figure 2

PHQ-9: Patient Health Questionnaire-9; TAU: treatment as usual